Clinical Trials in Kidney Cancer

Bayer and Onyx have multiple clinical trials underway for individuals with kidney cancer. For a more comprehensive list of Nexavar® (sorafenib) clinical trials in a variety of tumor types, please visit clinicaltrials.gov or call 1-866-639-2827.
 

Phase 3 Study of Nexavar Versus Sunitinib in Adjuvant Setting *

Study Design: Randomized, placebo-controlled study
Patients: Patients with advanced RCC that has been removed by surgery with no evidence of residual disease
Purpose: To compare the efficacy of Nexavar versus sunitinib versus placebo by assessing the differences in disease progression and overall survival
Location: Various sites in the United States
 

Phase 2 Study of Nexavar, Bevacizumab and Temsirolimus *

Study Design: Randomized, four-arm study
Patients: Patients with advanced RCC
Purpose: To compare the efficacy of different combinations of Nexavar, bevacizumab and temsirolimus by assessing differences in disease progression, as well as evaluate other measures of efficacy and safety
Location: United States

* Not a company-sponsored trial